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As a first step in an intervention study of asthma and allergic diseases among school children, a cross-sectional study 
was performed during Winter 1996 in three towns (Kiruna, Lules and Pitei) in the northernmost province of 
Sweden, Norrbotten. The cross-sectional study aimed to measure the prevalence of asthma, type-l allergy and 
allergic diseases in order to make it possible to measure the incidence of the diseases, conditions and symptoms 
related to the diseases. Another aim was to perform a screening for possible risk factors. All children enrolled in the 
first and second classes at school, 7 and 8 years old, were invited to take part in this study. The ISAAC questionnaire 
with added questions about symptoms, morbidity, heredity and environment was distributed by the schools to the 
parents. The response rate was 97%, and 3431 completed questionnaires were returned. The children in two of 
the municipalities were also invited to skin test, and 2149 (88%) were tested with 10 common airborne allergens. The 
results showed that 7% of the children were currently using or had used asthma medicines during the last 12 months. 
Six percent had asthma diagnosed by a physician, and 4% were using inhaled corticosteroids. The prevalence of 
wheezing during the last 12 months was 12%, rhinitis without colds 14%, and eczema 27%, while 21% had a positive 
skin test. The respiratory symptoms and conditions were significantly greater in boys and, further, they were most 
prevalent in Kiruna in the very north, though not significantly. Type-l allergy and asthma had different risk factor 
patterns. The main risk factors for asthma were a family history of asthma (ORz3.2) followed by past or present 
house dampness (OR= 1.9), male sex (OR= 1.7) and a smoking mother (OR= 1.6). In Kiruna, when none of these 
three risk factors were present, none of the children had asthma, but when all three were present, 38% of 
these children were using asthma medicines. 
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Introduction 
During the last three to four decades, the prevalence of 
asthma and allergic diseases has increased considerably in 
many countries, probably due to increased diagnostic inten- 
sity, altered diagnostic criteria and also a true increase in 
prevalence. Today, asthma and allergic diseases comprises 
the greatest group of diseases in children, adolescents and 
young adults in many parts of the world. The increase was 
first documented in Australia, New Zealand and the U.K., 
countries in which the increase also seems to be most 
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pronounced (l-6). Today, high prevalence of asthma and 
respiratory symptoms has been shown in children in later 
industrialized countries such as Chile (7) and Singapore (8). 
Prevalence rates in North America (9,lO) and Europe 
(1 l-l 3), particularly Central Europe (7,l l), are generally 
low in comparison with Australia and New Zealand. 
The incidence of asthma and allergic diseases reaches a 
peak in children of school age and younger (6,14-16). 
Asthma is strongly associated with type-l allergy (17). 
Type-l allergy shows a different sensitization profile in 
different environments and in different parts of the world. 
The dominating allergens may be pets such as cats or dogs 
(10,18), house-dust mites (19,20), pollen (21), moulds (22) 
and cockroaches (23,24). In the indoor environment, 
tobacco smoke (25-27) and dampness at home (25,27-29) 
are associated with an increased risk of asthma in children. 
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The role of outdoor air pollution as a risk factor for asthma 
is controversial (30-32); however, some studies report air 
pollution from traffic to be a risk factor for asthma (33-35). 
Other potential causes such as diet and respiratory infec- 
tions (36) are under debate. Although an increasing number 
of studies show similarities in the risk factor pattern for 
asthma, there is still no general agreement about why there 
has been such a marked increase. 
In Sweden, the prevalence of asthma has also increased, 
mainly in children (37) adolescents (15,16) and young 
adults (38). Comparative studies have pointed out that 
asthma is most prevalent in the north of the country 
(37,38), where mites and moulds hardly exist and conven- 
tional air pollution is low. This area is of particular interest 
in studying risk factors of the conditions and causes of the 
increasing prevalence of asthma. 
An intervention study aiming to reduce the incidence and 
morbidity of allergic diseases, mainly asthma, among 
school children in Northern Sweden started in 1996. The 
aim of this paper is to report prevalence rates of allergic 
conditions, mainly asthma, and risk factors for the 
conditions. 
Materials and Methods 
All school children in the towns and municipalities of 
Kiruna, Lulea and Pitea in Norrbotten, the northernmost 
province of Sweden, in the first and second classes at school 
were invited to take part in this study, which is planned to 
last for 8 years. The intervention focused on cleaning of the 
schools, active and passive smoking, and to increase the 
knowledge of allergy prevention according to a programme 
developed by the Swedish Institute of Public Health. 
The study started in February-April 1996 with a cross- 
sectional survey in order to estimate the prevalence of 
asthma, respiratory symptoms, rhinitis, eczema and type-l 
allergy, and to screen for risk factors for the conditions. 
The study was approved by the Ethical Committee at the 
University and the University Hospital of Northern Sweden 
in Umea. 
STUDY AREA 
The municipalities consist of both urban and rural areas. 
Two of them, Lulea and Pitea, are located on the Baltic Sea, 
and Kiruna is situated in the inland mountains north of the 
Arctic circle (Fig. 1). The climate in the two coastal 
municipalities is similar, with an average temperature of 
2°C (January - 11°C July 15°C) while the corresponding 
value for Kiruna is - 2°C (January - 15°C July 12°C). 
The relative humidity varies considerably between winter 
and summer. The winter in Kiruna lasts for 7-8 months, 
more than 1 month longer than in the coastal areas. 
The city of Lulea is the administrative, commercial and 
cultural centre of the province, and in 1996, it had 71 000 
inhabitants, of which 50 000 lived in the urban area. 
Furthermore, it has the largest steel industry in Sweden. 
Pitea had 41 000 inhabitants, of which approximately one 
half are living in the town of Pitea. Pitea has wood and 
FIG. 1. Map of Sweden and the province of Norrbotten 
with the towns Kiruna, Lulea and Pitea. 
paper-pulp industries. Kiruna includes a large area with 
mountains and had 26 000 inhabitants in 1996, of whom 
20 000 lived in the town. The biggest iron mine in Western 
Europe and airspace research are located to Kiruna. 
STUDY POPULATION 
All 3525 school children enrolled in the first and second 
classes were invited to participate in the study. They were 
7-8 years old with few exceptions, and 51% were boys. In 
all, 20 schools in Kiruna, 35 in Lulea and 26 in Pitea were 
enrolled. The study population and the participation rate 
are described in Table 1. 
METHODS 
A questionnaire with a covering letter explaining the aim of 
the study was distributed to the children’s parents by the 
school teachers. The response rate was 97%. In Kiruna and 
Lulea, the children were invited to have skin prick tests, and 
2114 (86%) were tested. In addition, 35 children had been 
skin tested prior to the study at the paediatric policlinics in 
Kiruna and Lulea. These results [total 2149 (88%)] have 
been included in the analysis. 
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TABLE 1. Study population: number of children who were invited and who participated in the 
questionnaire study and the skin test by area and sex 
Kiruna Lulea Pitea B G Total 
Questionnaire 
Invited 
Participated 
Skin test 
Invited 
Participated 
680 1774 1071 1797 1728 3525 
671 1757 1003 1750 1681 3431 
(99%) (99%) (94%) (97%) (97%) (97%) 
680 1774 1245 1209 2454 
617 1532 1073 1076 2149 
(91%) (86%) (86%) (89%) (88%) 
B, boys; G, girls. 
The questionnaire consisted of the core questions about 
wheezing and asthma, rhinitis and eczema from the ISAAC 
protocol (39). Additional questions about symptoms, use of 
medicines, family history of asthma or allergic diseases, 
demographic characteristics, and past and present living 
and environmental factors were added. Questions about 
mothers’ and fathers’ past and present smoking habits, past 
and present pets or other animals at home, and signs of 
dampness were included, as well as questions about hobbies 
and sport activities. 
The skin tests were carried out at school by two trained 
nurses. The tests were performed according to the standards 
developed by the European Academy of Allergology and 
Clinical Immunology (40). The allergen extracts used were 
from ALK and included a Swedish standard panel; birch, 
timothy, mugworth, dog, cat, horse, two mites (Dermato- 
phagoides farinae and D. pteronyssimus) and two moulds 
(Cladosporium and Alternaria). Histamine 10 mg ml ~ r and 
glycerol were used as positive and negative controls, 
respectively. A positive reaction was recorded if the mean 
diameter of the weal was >3 mm. 
DEFINITIONS 
The definitions were based on the answers to the following 
questions or combinations of questions: 
Ever wheeze: ‘Has your child ever had wheezing or whistling 
in the chest at any time in the past?’ 
Wheezing last 12 months: ‘Has your child had wheezing or 
whistling in the chest in the last 12 months?’ 
Ever asthma: ‘Has your child ever had asthma?’ 
Physician-diagnosed asthma: ‘Has the child been diagnosed 
by a physician as having asthma?’ 
Use of asthma medicines: ‘sometimes, often/periodically, or 
every day’ to the question ‘During the last 12 months, how 
often has your child taken medicines for asthma?’ 
Current asthma: subjects reporting physician-diagnosed 
asthma and either symptoms related to asthma during the 
last 12 months or use of asthma medicines during the last 
12 months. 
Asthma projle: subjects with ‘current asthma’, or wheezing 
during the last 12 months, or use of asthma medicines 
during the last 12 months. 
Ever rhinitis: ‘Has your child ever had a problem with 
sneezing or a runny or blocked nose when he/she did not 
have a cold?’ 
Rhinitis last I2 months: ‘In the past 12 months, has your 
child had a problem with sneezing or a runny or blocked 
nose when he/she did not have a cold?’ 
Physician-diagnosed rhinitis: subjects answer to the question 
‘Has the child been diagnosed by a physician as having 
allergic rhinitis or hayfever?’ 
Ever eczema: ‘Has your child ever had eczema?’ 
Eczema last 12 months: ‘Has your child had an itchy rash at 
any time in the last 12 months? 
Physician-diagnosed eczema: ‘Has the child been diagnosed 
by a physician as having eczema? 
ANALYSES 
Chi-square test was used for bi-variate comparisons. One- 
way ANOVA (analysis of variance) was used for test for 
trends. Odds ratios (OR) for various independent variables, 
which according to uni- or bi-variate analyses were associ- 
ated with increased or decreased risks for asthma or type-l 
allergy, were calculated by using multiple logistic regression 
analysis. 
Results 
ASTHMA AND WHEEZING 
‘Ever wheeze’ was reported by 21.2%, while wheezing 
during the last 12 months was reported by 11.7%. Wheezing 
without colds was reported by 5.8%, wheezing at or after 
physical exertion by 6.2%, sleep disturbed by wheezing by 
5.1%, and frequent periods of wheezing, more than 12 times 
per year, by 1.2%. 
Asthma diagnosed by physician was reported by 5.7%, 
while 7.1% reported they were using or had used asthma 
medicines during the last 12 months. The prevalence of the 
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TABLE 2. Prevalence of wheezing, use of asthma medicines and asthma by area and sex 
Symptom or condition 
Differences by 
Kiruna Lulea Pitea B G Total Area Sex 
Ever wheeze 19.8 21.4 21.9 24.2 18.2 21.2 0.586 <O.OOl 
Wheezing in last 12 months 13.6 11.3 11.0 12.9 10.4 11.7 0.220 0.016 
Sleep disturbed by wheezing in last 12 months 6.3 5.1 4.4 6.2 4.0 5.1 0.235 0,005 
Wheezing on or after exercise in last 12 months 7.2 6.1 5.8 7.4 5.0 6.2 0.45 1 0.003 
Wheezing without colds in last 12 months 7.2 5.7 5.2 6.7 4.9 5.8 0.243 0.028 
Ever asthma 7.0 6,4 5.8 7.8 4.9 6.4 0.623 <O.OOl 
Physician-diagnosed asthma 6.7 5.8 5.0 7.1 4.3 5.7 0.328 ~0~001 
‘Asthma profile’ 14.9 12.6 11.8 14.3 11.2 12.8 0.149 0.005 
‘Current asthma’ 6.6 5.2 4.8 6.5 4.2 5.3 0.253 0.002 
Use of asthma medicines 8.3 7.0 6.3 8.1 6.0 7.1 0.334 0.019 
Difference (P value) by area and sex. 
B, boys; G, girls. 
children with physician-diagnosed asthma and, further, 
either use of asthma medicines or symptoms related to 
asthma during the last 12 months, ‘current asthma’, was 
5.3%. A condition with ‘current asthma’ or, during the last 
12 months either wheezing or use of asthma medicines, 
‘asthma profile’, was reported by 12.8%. 
Asthma, use of asthma medicines and all respiratory 
symptoms were significantly more common in boys. There 
was a trend for asthma and most of the respiratory symp- 
toms, showing that they were most prevalent in the 
northernmost area, Kiruna. In Kiruna, 6% of the children 
were using or had used inhaled corticosteroids during the 
last 12 months, compared to 3.9% and 4.2% in Lulea and 
Pitea, respectively. Prevalence rates of asthma, wheezing 
and use of asthma medicines are described in Table 2. 
The prevalence of physician-diagnosed asthma also 
expresses the life time cumulative incidence of asthma. 
Presuming that the onset of asthma is rare before the age of 
1 year, the results indicate a mean annual incidence of 
asthma in this cohort of approximately 1 per 100 per year. 
The proportion of the subjects with physician-diagnosed 
asthma who had rhinitis during the last 12 months was 
46.7% (in boys, 46.8%, in girls, 47.9%). The corresponding 
figures for the proportion of subjects having rhinitis during 
the last 12 months who had physician-diagnosed asthma 
were 19.2”/ (in boys, 21.3”/0, in girls, 16.5”/0). Of the subjects 
with physician-diagnosed asthma, 46.7% had eczema dur- 
ing the last 12 months, similar in boys and girls. The 
proportion of subjects who had had eczema in the last 
12 months who had physician-diagnosed asthma was 9.9% 
(in boys, 13.0%, in girls, 6.7%1). 
RHINITIS AND ECZEMA 
‘Ever rhinitis’ was reported by 16.5%, rhinitis during the 
last 12 months by 14.0%, physician-diagnosed allergic rhini- 
tis or hayfever by 6.5%, and 9.1% were using medicines 
against rhinitis or hayfever. The conditions with rhinitis 
were significantly more common in boys, while only small 
differences were found between the three areas. 
‘Ever eczema’ was reported by 35.3%, eczema during the 
last 12 months by 27.20/o, physician-diagnosed eczema by 
13.4%, and 19.6% were using medicines against eczema. 
Eczema was significantly more common in girls. There were 
no significant differences between the three areas. 
Wheezing, rhinitis or eczema were reported by 38.9%, 
similar in boys and girls, and were most prevalent in 
Kiruna, 44.1% (P=O.O59). All three conditions were 
reported by 2.6% (in boys, 2.5%, in girls, 2.7%) and the 
prevalences were similar in the three areas. 
TYPE-1 ALLERGY 
Skin tests were performed in Kiruna and Lulea. The 
proportion of the children sensitized against cat was 13,40/o, 
dog 8.7%, birch 7.9%, timothy 6.7%, horse 6.1% and 
mugworth 0.9%. Further, 16.3% were sensitized against any 
of the three animals, and 12.8% against any of the three 
pollens. Only 1.4% were sensitized against any of the two 
moulds. In Kiruna, no girls and one boy were sensitized 
against house dust mites; the boy was not born in Kiruna 
but had moved to Kiruna in early childhood. In Kiruna, 
20.9% of the children were sensitized against at least one of 
the 10 allergens. The corresponding figure for Lulea was 
20.5%. A gender difference, though not significant (P=O.O6) 
was shown; 22.3”/0 of boys and 19.0% of girls had at least 
one positive skin test. Skin test results are shown in Table 3. 
Of those with physician-diagnosed asthma, 49% were 
sensitized against any of the 10 allergens. The correspond- 
ing figure for those with ‘current asthma’ was 52%, users of 
asthma medicines 48”/0, and users of inhaled corticosteroids 
53%. Of those with rhinitis during the last 12 months, 47% 
were sensitized against any of the 10 allergens, while the 
corresponding figure for those having physician-diagnosed 
allergic rhinitis or hay fever was 75%, and physician- 
diagnosed eczema was 38%. Of the 3% with wheezing, 
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TABLE 3. Prevalence of positive skin test by area and sex 
Differences by 
Allergen Kiruna Lulea M F Total Area Sex 
Birch 55 8.9 9.2 6.7 I.9 0.008 0.038 
Timothy 7.1 6.5 8.1 5.2 6.7 0.568 0.007 
Mugwort 0.8 1.0 1.0 0.8 0.9 0.809 0.662 
Any pollen 11.0 12.9 14.5 10.3 12.4 0.247 0.004 
Cat 13.5 13.3 14.6 12.2 
Dog 10.1 8.1 9.3 8.1 
Horse 6.0 6.1 7.4 4.8 
Any animal 17.0 16.0 17.1 15.5 
Derm. pter. 0.2 0.7 0.8 0.2 
3.4 0.944 0.113 
8.7 0.150 0.358 
6.1 1.000 0.011 
6.3 0.561 0.320 
0.5 0.194 0.038 
Derm. farinae 0 0.9 1.3 0 0.7 0.015 <O.OOl 
Any mite 0.2 1.3 1.7 0.2 0.9 0.022 <O.OOl 
Cladospor 0.7 1.3 1.5 0.7 1.1 0.257 0.104 
Alternaria 0.2 0.7 0.9 0.3 0.6 0.198 0.089 
Any mould 0.8 1.6 1.9 0.8 1.4 0.216 0.041 
Any allergen 20.9 20.5 22.3 19.0 20.6 0.860 0.062 
Difference (P value) by area and sex. 
B, boys; G, girls. 
Physician-diagnosed asthma 
Use of inhaled steroids in last 12 months 
Physician-diagnosed rhinitis 
Physician-diagnosed eczema 
No symptoms in last 12 months 
0 10 20 30 40 50 60 70 80 
% 
FIG. 2. The proportion of the children with asthma, rhinitis, eczema, or without any allergy-related condition, who are 
sensitized to at least one of 10 common allergens. 
rhinitis and eczema, 58% were sensitized against any of the 
10 allergens. Of those without any of the three symptoms or 
conditions during the last 12 months, 12% were sensitized 
against any of the 10 allergens. The proportions of sensi- 
tized children among those with different conditions and 
symptoms are shown in Fig. 2. 
Of the 20.6% who were sensitized against any of the 10 
allergens, 15.3% reported that they had asthma diagnosed 
by a physician, 26.4% physician-diagnosed allergic rhinitis 
or hay fever, 27.1% physician-diagnosed eczema, and 48.1% 
either asthma, rhinitis or eczema diagnosed by a physician. 
MULTIVARIATE RELATIONSHIPS 
When calculating risks by using multiple logistic regression 
analysis for different dependent variables expressing con- 
ditions related to asthma, the Odds Ratios (OR) increased 
when specificity increased. Highest risks were found when 
the condition ‘current asthma’ was used as the dependent 
variable. Significant risk factors were a family history of 
asthma (OR 3.2) past or present house dampness (OR 1.9), 
mother who smoked (OR 1.6), and male sex (OR 1.7) 
(Table 4). The condition ‘asthma profile’ showed a similar 
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TABLE 4. Risk factors for ‘asthma profile’, use of asthma medicines and ‘current asthma’ by multiple logistic regression 
analysis 
Independent variables Dependent variables 
‘Asthma profile’ Asthma med. ‘Current asthma’ 
Variables Categories OR P value OR P value OR P value 
Sex 
Asthma heredity 
House dampness 
Mother smoker 
Pets at home 
Area of domicile 
Girl 1 
BOY 1.3 
No 1 
Yes 2.5 
No 1 
Yes 1.6 
No 1 
Yes 1.3 
No 1 
Yes 0.15 
Pitea 1 
Lulea 0.95 
Kiruna 1.12 
1 
0.01 1.4 
1 
0~0000. 3.0 
1 
0.0004 1.6 
1 
0.05 1.5 
1 
0.01 0.64 
1 
0.70 1.04 
0.46 1.18 
1 
0.03 1.7 0.002 
1 
0.0000. 3.2 0~0000. 
1 
0.005 1.9 0.0007 
1 
0.006 1.6 0.009 
1 
0.004 0.64 0.006 
1 
0.84 1.03 0.88 
0.44 1.25 0.34 
Risks in odds ratios (OR). 
TABLE 5. Risk factors for any positive skin test by multiple logistic regression analysis 
Independent variables Dependent variable 
Any positive skin test 
Variables Categories OR P value 
Sex 
Family history of allergic disease 
Mother smoker 
House dampness 
Home 
Urban/rural 
Animals at home 
Area of domicile 
Girl 1 
BOY 1.18 
No 1 
Yes 1.65 
No 1 
Yes 0.80 
No 1 
Yes 0.92 
House 1 
Apartment 1.10 
Rural 1 
Urban 1.41 
No 1 
Yes 0.86 
Kiruna 1 
Lulea 0.99 
0.16 
0.0005 
0.10 
0.58 
0.46 
0.015 
0.25 
0.96 
Risks in odds ratios (OR). 
risk factor pattern, however, the risks were lower. Resi- 
dence in the northernmost located Kiruna was associated 
with an elevated risk, though not significantly (OR 1.3). 
Past or present experience of cats, dogs or other pets at 
home showed significantly lower risks for all outcome 
variables related to asthma. 
Of the factors used in the model, only a family history of 
either asthma, rhinitis or eczema (OR 1.7), and urban 
residence (OR 1.4), were associated with significantly 
elevated risks for type-l allergy (Table 5). Past or present 
experience of cats, dogs or other pets at home were also, 
as for asthma, not associated with elevated risks for 
type-l allergy. 
The risk of developing ‘current asthma’ (expressed in OR 
for the children with a family history of asthma, past or 
present problems with dampness in their homes and a 
smoking mother) was 8 compared with the children without 
these risk factors (Fig. 3). That risk factor pattern was most 
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FIG. 3. Risks for asthma in relation to a family history of 
asthma (h), a smoking mother (s), and dampness at home 
(d). The dependent variable is ‘current asthma’. Odds 
ratios (OR) calculated by multiple logistic regression 
analysis. 
pronounced in Kiruna, where 38% of the children with the 
three abovementioned risk factors. were currently using 
asthma medicines, while none of those without any of these 
three risk factors had asthma diagnosed by a physician or 
were using asthma medicines. 
Discussion 
In order to collect basic data for a longitudinal intervention 
study on allergic diseases, mainly asthma, an extensive 
screening of symptoms, diseases and different background 
data was performed. The ISAAC questionnaire (39) was 
chosen, as it gives good possibilities to make comparisons 
with other studies. Further, the questionnaire has been 
validated (1 l), it has been translated to Swedish, and it has 
been used in Sweden (41). The very high response rate and 
the use of the ISAAC questionnaire contribute to the 
validity of the results, and establish a good start for the 
longitudinal study. 
Asthma diagnosed by a physician was reported by 6%, 
while 7% reported that they had used asthma medicines and 
12% reported that they had wheezed during the last 12 
months. The prevalence of physician-diagnosed asthma in 
children of similar ages in Scandinavia has recently been 
reported to be 448% in Sweden (37,42), S-9% in Norway 
(16,42), and around 4% in different parts of Finland (42,43). 
In lo-year-old children in West and East Germany, the 
prevalence has been reported to be 9 and 7% respectively 
(1 l), while in Australia (3,5,7) and Chile (7) a prevalence of 
more than 20% has been reported. The big differences in the 
prevalence rates may, in part, be related to differences in 
study methods and also to different diagnostic criteria. In 
the present study we found the ratio between the prevalence 
of wheezing during the last 12 months and asthma to be 2.0. 
The corresponding figure from Norway was 1.3 (16) and 
Australia 0.96 (7) which strongly suggest that different 
diagnostic criteria have been used in different countries. 
The prevalence of ‘current asthma’, which included sub- 
jects with physician-diagnosed asthma and either use of 
asthma medicines or wheezing during the last 12 months, 
was 5%. These criteria give a high specificity but lower 
sensitivity, and consequently the prevalence of asthma will 
be somewhat underestimated by using the criteria for 
estimating prevalence. The situation is the opposite for the 
condition ‘asthma profile’, which results in a high sensitivity 
but a low specificity, and the prevalence of the condition 
was 13%. When comparing the results with Australian data, 
‘asthma profile’ may be a suitable condition for compari- 
son. As a consequence of this discussion, the authors 
believe that a ‘true’ prevalence of asthma following 
Scandinavian diagnostic practice in this cohort is close to 
that defined by use of asthma medicines, or around 7%. The 
prevalence is similar to that which was found in somewhat 
older children in Kiruna in 1991 (37), and reported from 
Sundsvall on the Baltic See in Northern Sweden 550 km 
south of Lulea (44). 
A family history of asthma was found to be the strongest 
risk factor for current asthma (OR=3.2), stronger than in 
other Swedish studies in children (45). Also a mother who 
smoked was found to be a greater risk factor for asthma 
than environmental tobacco smoke has been found to be in 
previous studies (25,42), on the other hand, maternal smok- 
ing did not appear as a risk factor for allergic sensitization 
in this study, as has been shown in some other studies 
(27,46). Dampness at home was associated with an 
increased risk of asthma, which is in accordance with other 
studies (25,27,28). The mechanism for this is unknown, but 
a possible explanation may include poor ventilation that 
concentrates indoor emissions. In the present study, mites 
were not a likely explanation for the relationship between 
asthma and dampness, since sensitization against mite was 
uncommon. Bias from the reporting parents may occur. 
Increased awareness or over reporting of exposure among 
parents with children with asthma problems may, however, 
affect the results for building exposure more than for 
personal exposure, such as smoking at home. 
The study results made it possible to define a group with 
a considerably increased risk to develop asthma. Those 
with a family history of asthma, past or present problems 
with dampness in their homes, and a smoking mother had a 
considerably greater risk (OR 8) of developing asthma than 
those without these risks; in fact, without these risk factors, 
the prevalence of asthma was very low. 
Earlier studies have shown a north-south gradient of 
asthma with higher prevalence in the north (37,38). The 
present study found higher prevalence of symptoms, dis- 
eases and use of asthma medicines in Kiruna in the north, 
compared with Pitea and Lulea on the Baltic Sea, while the 
prevalence of positive skin tests was similar in Kiruna and 
Lulea. A hypothesis to explain the higher prevalence of 
respiratory symptoms in the north may be that the longer 
and colder winters may cause people to spend more time 
indoors, so that they are more exposed to emissions from 
buildings and to other indoor environmental exposures. 
The prevalence of eczema and rhinitis were higher than 
found in Kiruna in 1991 in somewhat older children (37). 
As with the data for asthma, a higher prevalence of rhinitis 
was found in boys, but girls had a higher prevalence of 
eczema. This age-dependent gender distribution is consist- 
ent with results from other studies (16,37,42,45). Wheezing, 
rhinitis or eczema during the last 12 months was reported 
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by 39% in this very young cohort. Studies in teenagers have 
reported similar prevalence rates (45). For both rhinitis and 
eczema, big differences were found in the prevalence of 
children answering different questions screening the con- 
ditions. This may reflect differences in degree of severity of 
the diseases. 
Twenty-one percent were sensitized to one or more of the 
allergens used for testing. The most common allergen was 
cat, while less than 1% were sensitized against mites. Many 
studies have shown a close relation between allergic sensi- 
tization to airborne allergens and asthma (10,12,18,44). Of 
the asthmatic children in this study, around half were 
sensitized against at least one of the tested allergens. The 
corresponding proportion was 75% for the children with a 
physician’s diagnosis of rhinitis. An interesting and import- 
ant finding was that the risk factor patterns for asthma and 
type-l allergy were different. This indicates that these 
conditions have, at least in part, different aetiology even if 
they are closely related and often occur together. The only 
factor which was significantly associated with an increased 
risk for type-l allergy, in addition to family history of 
allergic disease, was urban living. This has been shown 
previously in some Scandinavian studies (44) but not in 
others (42). The decreased risk for asthma, as well as for 
atopic sensitization associated with exposure to pets, may 
be due to avoidance of pets in families with a history of 
atopic diseases. 
In conclusion, this study confirms that allergic diseases 
are common among school children in Northern Sweden. 
The prevalence of asthma was around 7%; that of rhinitis 
was twice, type-l allergy thrice and of eczema four times 
that of asthma. The risk of having asthma was eight (OR) 
times greater if the children had a family history of asthma, 
a smoking mother, and were or had been living in a house 
with dampness problems compared with the children with- 
out these risk factors. 
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